BDBM63214 3-(2,6-dimethylphenyl)-1-(2-methoxyethyl)-1-(1-pyridin-3-ylethyl)thiourea::3-(2,6-dimethylphenyl)-1-(2-methoxyethyl)-1-[1-(3-pyridinyl)ethyl]thiourea::3-(2,6-dimethylphenyl)-1-(2-methoxyethyl)-1-[1-(3-pyridyl)ethyl]thiourea::MLS000584540::N'-(2,6-dimethylphenyl)-N-(2-methoxyethyl)-N-(1-pyridin-3-ylethyl)thiourea::SMR000207126::cid_4124866

SMILES Cc1cccc(-c2nn(CC(=O)Nc3cc(F)cc(C(=O)OC45CCN(CC4)CC5)c3)cc2-c2ccnc3ccccc23)n1

InChI Key InChIKey=OPACOYYWGYTZSP-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63214   

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63214BDBM63214(quinuclidin-4-yl 3-fluoro-5-(2-(3-(6-methylpyridin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent